Evidence map›Paper›PMID 32556382›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2020

Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control.

Marcial García, Luis López-Fernández, Pablo Mínguez, Sara Morón-López, Clara Restrepo, María A Navarrete-Muñoz, Juan Carlos López-Bernaldo, Alberto Benguría, María Isabel García, Alfonso Cabello and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. The reservoir of latent HIV.Frontiers in cellular and infection microbiology · 2022
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Marcial GarcíaHIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Av. Reyes Católicos, 2, 28040, Madrid, Spain.
Luis López-FernándezPharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Pablo MínguezBioinformatics Unit, Genetics Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.
Sara Morón-LópezirsiCaixa AIDS Research Institute, Badalona, Spain.
Clara RestrepoHIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Av. Reyes Católicos, 2, 28040, Madrid, Spain.
María A Navarrete-MuñozHIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Av. Reyes Católicos, 2, 28040, Madrid, Spain.
Juan Carlos López-BernaldoHospital General Universitario Gregorio Marañón, Madrid, Spain.
Alberto BenguríaGenomics Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
María Isabel GarcíaPharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Alfonso CabelloHospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Manuel Fernández-GuerreroHospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Francisco Javier De la HeraHospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Vicente EstradaHospital Universitario Clínico San Carlos, Madrid, Spain.
Carlos BarrosHospital Universitario de Móstoles, Móstoles, Spain.
Javier Martínez-PicadoirsiCaixa AIDS Research Institute, Badalona, Spain.
Miguel GórgolasHospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
José M BenitoHIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Av. Reyes Católicos, 2, 28040, Madrid, Spain. jbenito1@hotmail.com.ORCID https://orcid.org/0000-0002-7172-049X
Norma RallónHIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Av. Reyes Católicos, 2, 28040, Madrid, Spain. normaibon@yahoo.com.ORCID https://orcid.org/0000-0002-4643-247X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The HIV reservoir is the main barrier to eradicating HIV infection, and resting memory CD4 T (Trm) cells are one of the most relevant cellular component harboring latent proviruses. This is the first study analyzing the transcriptional profile of Trm cells, in two well-characterized groups of HIV patients with distinct mechanisms of viral replication control (spontaneous versus treatment-induced). We use a systems biology approach to unravel subtle but important differences in the molecular mechanisms operating at the cellular level that could be associated with the host's ability to control virus replication and persistence. Despite the absence of significant differences in the transcriptome of Trm cells between Elite Controllers (ECs) and cART-treated (TX) patients at the single gene level, we found 353 gene ontology (GO) categories upregulated in EC compared with TX. Our results suggest the existence of mechanisms at two different levels: first boosting both adaptive and innate immune responses, and second promoting active viral replication and halting HIV latency in the Trm cell compartment of ECs as compared with TX patients. These differences in the transcriptional profile of Trm cells could be involved in the lower HIV reservoir observed in ECs compared with TX individuals, although mechanistic studies are needed to confirm this hypothesis. Combining transcriptome analysis and systems biology methods is likely to provide important findings to help us in the design of therapeutic strategies aimed at purging the HIV reservoir. KEY MESSAGES: HIV-elite controllers have the lowest HIV-DNA content in resting memory CD4 T cells. HIV-ECs show a particular transcriptional profile in resting memory CD4 T cells. Molecular mechanisms of enhanced adaptative and innate immune response in HIV-ECs. High viral replication and low viral latency establishment associate to the EC status.

Indexed as

Host-Pathogen InteractionsImmunologic MemoryTranscriptomeAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountCD4-Positive T-LymphocytesGene Expression ProfilingHIV InfectionsHumansTreatment OutcomeViral LoadVirus ReplicationElite controllersHIV reservoirResting memory CD4 T cellsTranscriptional signatureViral control

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.